172 related articles for article (PubMed ID: 2895675)
21. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia.
Maeda M; Arima N; Daitoku Y; Kashihara M; Okamoto H; Uchiyama T; Shirono K; Matsuoka M; Hattori T; Takatsuki K
Blood; 1987 Nov; 70(5):1407-11. PubMed ID: 2889484
[TBL] [Abstract][Full Text] [Related]
22. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.
Reddy MM; Grieco MH
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):115-20. PubMed ID: 2966633
[TBL] [Abstract][Full Text] [Related]
23. Normal expression of p55 interleukin 2 receptor (CD25) by lymphocytes from former blood donors seropositive for human T lymphotropic virus.
Prince HE; Jackson AL
Clin Immunol Immunopathol; 1990 Dec; 57(3):459-64. PubMed ID: 1700938
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
[TBL] [Abstract][Full Text] [Related]
25. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
26. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K
Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781
[TBL] [Abstract][Full Text] [Related]
27. Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease.
Damle RN; Advani SH; Gangal SG
Int J Cancer; 1992 Jan; 50(2):192-6. PubMed ID: 1730512
[TBL] [Abstract][Full Text] [Related]
28. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
[TBL] [Abstract][Full Text] [Related]
29. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
Hurteau JA; Woolas RP; Jacobs IJ; Oram DC; Kurman CC; Rubin LA; Nelson DL; Berchuck A; Bast RC; Mills GB
Cancer; 1995 Nov; 76(9):1615-20. PubMed ID: 8635066
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.
Prin L; Plumas J; Gruart V; Loiseau S; Aldebert D; Ameisen JC; Vermersch A; Fenaux P; Bletry O; Capron M
Blood; 1991 Nov; 78(10):2626-32. PubMed ID: 1726707
[TBL] [Abstract][Full Text] [Related]
31. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum-soluble interleukin-2 receptor (Tac antigen) levels in chronic myelogenous leukemia patients with blastic crisis.
Motoi T; Uchiyama T; Hori T; Itoh K; Uchino H; Ueda R
Blood; 1989 Aug; 74(3):1052-7. PubMed ID: 2787681
[TBL] [Abstract][Full Text] [Related]
33. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL.
Yamaguchi K; Kiyokawa T; Nakada K; Yul LS; Asou N; Ishii T; Sanada I; Seiki M; Yoshida M; Matutes E
Br J Haematol; 1988 Feb; 68(2):169-74. PubMed ID: 2894835
[TBL] [Abstract][Full Text] [Related]
34. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
[TBL] [Abstract][Full Text] [Related]
35. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
36. High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: correlation with poor prognosis and CD4 expression on blast cells.
Nakase K; Kita K; Kyo T; Tsuji K; Katayama N
Cancer Epidemiol; 2012 Oct; 36(5):e306-9. PubMed ID: 22537764
[TBL] [Abstract][Full Text] [Related]
37. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.
Yamaguchi K; Watanabe T
Int J Hematol; 2002 Aug; 76 Suppl 2():240-5. PubMed ID: 12430931
[TBL] [Abstract][Full Text] [Related]
38. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
39. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
40. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients.
Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH
J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
